针对非小细胞肺癌的新辅助向治疗及其对手术结果的影响
Mark Sorin1,2, Caroline Huynh1,3, Merav Rokah3
1Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, Quebec, Canada.
Annals of thoracic surgery short reports
|January 10, 2025
概括
针对非小细胞肺癌 (NSCLC) 的新辅助向治疗显示出潜力,但需要进一步研究. 这种方法影响了手术结果和整体患者体验,强调了在治疗规划中需要仔细考虑的需要.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对非小细胞肺癌 (NSCLC) 的新辅助向治疗存在有限的证据.
- 目前,有两项第三阶段试验正在招募,并且该治疗策略尚未批准任何指示.
研究的目的:
- 在可操作的非小细胞肺癌 (NSCLC) 中描述新辅助向治疗的临床经验.
- 突显手术结果的重要性,作为NSCLC新辅助疗法的不足报告的方面.
主要方法:
- 对接受新辅助向治疗的可手术的非小细胞肺癌 (NSCLC) 患者的回顾性审查.
- 对手术结果的分析,包括与治疗相关的潜在益处和风险.
主要成果:
- 手术结果是非小细胞肺癌 (NSCLC) 新辅助向治疗的关键,但未得到充分报道的组成部分.
- 新辅助药物向治疗的应用既带来了显著的潜在益处,也带来了影响手术规划和执行的风险.
结论:
- 新辅助向治疗显著影响患者在非小细胞肺癌 (NSCLC) 治疗中的体验.
- 对手术规划,策略和结果的影响需要仔细评估,以获得最佳的患者护理.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
381
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K